• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体内心脏类器官的证据评价与人类心脏发育的协调性。

An evidence appraisal of heart organoids in a dish and commensurability to human heart development in vivo.

机构信息

Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.

出版信息

BMC Cardiovasc Disord. 2022 Mar 22;22(1):122. doi: 10.1186/s12872-022-02543-7.

DOI:10.1186/s12872-022-02543-7
PMID:35317745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8939187/
Abstract

Stem-cell derived in vitro cardiac models have provided profound insights into mechanisms in cardiac development and disease. Efficient differentiation of specific cardiac cell types from human pluripotent stem cells using a three-step Wnt signaling modulation has been one of the major discoveries that has enabled personalized cardiovascular disease modeling approaches. Generation of cardiac cell types follow key development stages during embryogenesis, they intuitively are excellent models to study cardiac tissue patterning in primitive cardiac structures. Here, we provide a brief overview of protocols that have laid the foundation for derivation of stem-cell derived three-dimensional cardiac models. Further this article highlights features and utility of the models to distinguish the advantages and trade-offs in modeling embryonic development and disease processes. Finally, we discuss the challenges in improving robustness in the current models and utilizing developmental principles to bring higher physiological relevance. In vitro human cardiac models are complimentary tools that allow mechanistic interrogation in a reductionist way. The unique advantage of utilizing patient specific stem cells and continued improvements in generating reliable organoid mimics of the heart will boost predictive power of these tools in basic and translational research.

摘要

基于干细胞的体外心脏模型为心脏发育和疾病的机制研究提供了深刻的见解。使用三步 Wnt 信号调节有效地将特定的人心肌细胞类型从多能干细胞中分化出来,这是能够实现个性化心血管疾病建模方法的主要发现之一。生成的心肌细胞类型遵循胚胎发生过程中的关键发育阶段,它们直观上是研究原始心脏结构中心脏组织模式形成的优秀模型。在这里,我们简要概述了为衍生基于干细胞的三维心脏模型奠定基础的方案。此外,本文还强调了这些模型的特点和用途,以区分在模拟胚胎发育和疾病过程中的优势和权衡。最后,我们讨论了提高当前模型稳健性并利用发育原理提高生理相关性的挑战。体外人心肌模型是互补工具,可以以简化的方式进行机制研究。利用患者特异性干细胞的独特优势以及在生成可靠的心脏类器官模拟物方面的持续改进,将提高这些工具在基础和转化研究中的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1598/8939187/757b6f779190/12872_2022_2543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1598/8939187/757b6f779190/12872_2022_2543_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1598/8939187/757b6f779190/12872_2022_2543_Fig1_HTML.jpg

相似文献

1
An evidence appraisal of heart organoids in a dish and commensurability to human heart development in vivo.在体内心脏类器官的证据评价与人类心脏发育的协调性。
BMC Cardiovasc Disord. 2022 Mar 22;22(1):122. doi: 10.1186/s12872-022-02543-7.
2
A Robust Pipeline for the Multi-Stage Accelerated Differentiation of Functional 3D Cortical Organoids from Human Pluripotent Stem Cells.一种稳健的多阶段加速分化人多能干细胞为功能性 3D 皮质类器官的流水线。
Curr Protoc. 2023 Jan;3(1):e641. doi: 10.1002/cpz1.641.
3
Cellular and Engineered Organoids for Cardiovascular Models.用于心血管模型的细胞和工程类器官
Circ Res. 2022 Jun 10;130(12):1780-1802. doi: 10.1161/CIRCRESAHA.122.320305. Epub 2022 Jun 9.
4
Dynamic 3D Combinatorial Generation of hPSC-Derived Neuromesodermal Organoids With Diverse Regional and Cellular Identities.动态 3D 组合生成具有不同区域和细胞特征的 hPSC 衍生神经中胚层类器官。
Curr Protoc. 2022 Oct;2(10):e568. doi: 10.1002/cpz1.568.
5
From Spheroids to Organoids: The Next Generation of Model Systems of Human Cardiac Regeneration in a Dish.从球体到类器官:在体外培养皿中进行人类心脏再生的下一代模型系统。
Int J Mol Sci. 2021 Dec 7;22(24):13180. doi: 10.3390/ijms222413180.
6
Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases.从多能干细胞中生成稳健的人腔心脏类器官,用于改善心血管疾病的建模。
Stem Cell Res Ther. 2022 Dec 21;13(1):529. doi: 10.1186/s13287-022-03215-1.
7
Heart in a dish - choosing the right in vitro model.器官芯片 - 选择合适的体外模型
Dis Model Mech. 2023 May 1;16(5). doi: 10.1242/dmm.049961. Epub 2023 Feb 24.
8
Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.人多能干细胞衍生的肺类器官:在发育和疾病建模中的潜在应用。
Wiley Interdiscip Rev Dev Biol. 2021 Nov;10(6):e399. doi: 10.1002/wdev.399. Epub 2020 Nov 3.
9
In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.在 3D 生物打印的有腔类器官中,人心脏肌肉的原位扩增、分化和机电耦联。
Circ Res. 2020 Jul 3;127(2):207-224. doi: 10.1161/CIRCRESAHA.119.316155. Epub 2020 Mar 31.
10
Pluripotent stem cell-derived organoids: using principles of developmental biology to grow human tissues in a dish.多能干细胞衍生的类器官:利用发育生物学原理在培养皿中培育人体组织。
Development. 2017 Mar 15;144(6):958-962. doi: 10.1242/dev.140731.

引用本文的文献

1
Integrative approaches in cardiac tissue engineering: Bridging cellular complexity to create accurate physiological models.心脏组织工程中的整合方法:弥合细胞复杂性以创建精确的生理模型。
iScience. 2025 Jun 25;28(8):113003. doi: 10.1016/j.isci.2025.113003. eCollection 2025 Aug 15.
2
Potential Use of Organoids in Regenerative Medicine.类器官在再生医学中的潜在应用
Tissue Eng Regen Med. 2024 Dec;21(8):1125-1139. doi: 10.1007/s13770-024-00672-y. Epub 2024 Oct 16.
3
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID.

本文引用的文献

1
Co-emergence of cardiac and gut tissues promotes cardiomyocyte maturation within human iPSC-derived organoids.心脏和肠道组织的共出现促进了人诱导多能干细胞衍生类器官中心肌细胞的成熟。
Cell Stem Cell. 2021 Dec 2;28(12):2137-2152.e6. doi: 10.1016/j.stem.2021.11.007.
2
Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease.用于心脏发育和先天性心脏病建模的自组装人心类器官。
Nat Commun. 2021 Aug 26;12(1):5142. doi: 10.1038/s41467-021-25329-5.
3
Cardioids reveal self-organizing principles of human cardiogenesis.
CCL2 介导体内皮损伤导致长新冠心脏功能障碍。
Nat Cardiovasc Res. 2024 Oct;3(10):1249-1265. doi: 10.1038/s44161-024-00543-8. Epub 2024 Oct 14.
4
Next-Gen Therapeutics: Pioneering Drug Discovery with iPSCs, Genomics, AI, and Clinical Trials in a Dish.下一代疗法:利用诱导多能干细胞、基因组学、人工智能以及体外临床试验开拓药物研发。
Annu Rev Pharmacol Toxicol. 2025 Jan;65(1):71-90. doi: 10.1146/annurev-pharmtox-022724-095035. Epub 2024 Dec 17.
5
Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer.癌症治疗中的心血管毒性:在抗癌的同时保护心脏。
Curr Cardiol Rep. 2024 Sep;26(9):953-971. doi: 10.1007/s11886-024-02099-2. Epub 2024 Jul 23.
6
Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids.免疫抑制剂他克莫司和西罗莫司可逆转3D多细胞人诱导多能干细胞心脏类器官中p38丝裂原活化蛋白激酶抑制的心脏抗纤维化特性。
Front Cell Dev Biol. 2022 Nov 11;10:1001453. doi: 10.3389/fcell.2022.1001453. eCollection 2022.
心形线揭示了人类心脏发生的自组织原理。
Cell. 2021 Jun 10;184(12):3299-3317.e22. doi: 10.1016/j.cell.2021.04.034. Epub 2021 May 20.
4
Generation of Vascular Smooth Muscle Cells From Induced Pluripotent Stem Cells: Methods, Applications, and Considerations.诱导多能干细胞生成血管平滑肌细胞:方法、应用及注意事项。
Circ Res. 2021 Mar 5;128(5):670-686. doi: 10.1161/CIRCRESAHA.120.318049. Epub 2021 Mar 4.
5
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells.使用人诱导多能干细胞衍生的心肌细胞、心脏成纤维细胞和内皮细胞制造三维心脏微组织阵列。
J Vis Exp. 2021 Mar 14(169). doi: 10.3791/61879.
6
Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.人诱导多能干细胞在心血管研究中的应用:心脏分化的当前方法、成熟策略和可扩展生产。
Cardiovasc Res. 2022 Jan 7;118(1):20-36. doi: 10.1093/cvr/cvab115.
7
Cardiac Tissues From Stem Cells: New Routes to Maturation and Cardiac Regeneration.从干细胞到心脏组织:走向成熟和心脏再生的新途径。
Circ Res. 2021 Mar 19;128(6):775-801. doi: 10.1161/CIRCRESAHA.121.318183. Epub 2021 Mar 18.
8
Building Multi-Dimensional Induced Pluripotent Stem Cells-Based Model Platforms to Assess Cardiotoxicity in Cancer Therapies.构建基于多维度诱导多能干细胞的模型平台以评估癌症治疗中的心脏毒性。
Front Pharmacol. 2021 Feb 18;12:607364. doi: 10.3389/fphar.2021.607364. eCollection 2021.
9
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017.心血管疾病死亡率、发病率及死亡率与发病率之比的趋势分析:全球疾病负担研究2017结果
BMC Public Health. 2021 Feb 25;21(1):401. doi: 10.1186/s12889-021-10429-0.
10
Decoding Genetics of Congenital Heart Disease Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs).利用患者来源的诱导多能干细胞(iPSCs)解码先天性心脏病的遗传学
Front Cell Dev Biol. 2021 Jan 21;9:630069. doi: 10.3389/fcell.2021.630069. eCollection 2021.